For example, MAP2K3 (MKK3) has been proposed as a tumor suppressor in breast cancer (MacNeil et al., 2014) thus suggesting that the inhibition of p38MAPK signaling pathway could be counterproductive in this type of tumors. This evidence concerns the gene MAP2K3 and neoplasm.